Concepedia

Zoë Johnson

ZJ

26

Publications

2.5K

Citations

21

H-Index

2003

Active since

Affiliations

Light Chain Bioscience (Switzerland)(Current)

Merck Serono (Switzerland)

University of Graz

University of California San Diego

University of Regensburg

Zoë Johnson is an author at Light Chain Bioscience (Switzerland) specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2003–2023

26

Publications

26

Glycosaminoglycan binding and oligomerization are essential for the <i>in vivo</i> activity of certain chemokines

Amanda E. I. Proudfoot, Tracy M. Handel, Zoë Johnson et al. · Proceedings of the National Academy of Sciences · 2003 · 764 citations

Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1

Elaine K. Lau, Chad D. Paavola, Zoë Johnson et al. · Journal of Biological Chemistry · 2004 · 201 citations · Full text

Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System

Zoë Johnson, Marie Kosco‐Vilbois, Suzanne Herren et al. · The Journal of Immunology · 2004 · 155 citations · Full text

, , +23

Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies

Elie Dheilly, Valéry Moine, Lucile Broyer et al. · Molecular Therapy · 2017 · 135 citations · Full text

Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG

Nicolas Fischer, Greg Elson, Giovanni Magistrelli et al. · Nature Communications · 2015 · 117 citations · Full text

Rows per page

1–5 of 26